Pharmaceutical - Novo Nordisk, Global


Current filters:

Novo NordiskGlobal

Popular Filters

Global insulin market set to reach $32.24 billion in 2019

Global insulin market set to reach $32.24 billion in 2019


The global insulin market was valued at $19.99 billion in 2012 and is expected to expand at a compound…

AfrezzaChinaDiabetesEli LillyGlobalInsulinLY2605541MannKindMarkets & MarketingMerck & CoMK-1293NN1218Novo NordiskPharmaceutical

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review


Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

Global diabetes drugs market led by Novo Nordisk and Sanofi


The global diabetes drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

DiabetesGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

High demand for monoclonal antibodies will drive therapeutic proteins market


The global therapeutic proteins market will grow at a moderate pace, with monoclonal antibodies considered…

AmgenBiotechnologyGlobalMarkets & MarketingNovo NordiskPharmaceuticalRoche

Back to top